A comparison of the effectiveness of soy protein isolate and fish oil for reducing the severity of retinoid-induced hypertriglyceridemia

Journal of Nutritional Biochemistry

Volumn 15, Issue 3, 2004, Pages 163-168

  Radcliffe, John D ^a,b   Czajka Narins, Dorice M ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Fish oil; Hypertriglyceridemia; Retinoids; Soy protein

Indexed keywords

CASEIN; CORN OIL; FISH OIL; ISOTRETINOIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FOOD COMPOSITION; FOOD INTAKE; HYPERTRIGLYCERIDEMIA; LIPID COMPOSITION; MALE; NONHUMAN; RAT; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BODY WEIGHT; DIETARY SUPPLEMENTS; FISH OILS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MALE; RATS; RATS, INBRED F344; RETINOIDS; SOYBEAN PROTEINS; TIME FACTORS; TRIGLYCERIDES;

ANIMALIA; ZEA MAYS;

EID: 1542408823     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2003.08.012     Document Type: Article

References (53)

1. Klaassen I., Braakhuis B.J. Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer. Oral Oncol. 38:2002;532-542.
2. Triozzi P.L., Walker M.J., Pellegrini A.E., Dayton M.A. Isotretinoin and recombinant interferon alfa-2 therapy of metastatic malignant melanoma. Cancer Invest. 14:1996;293-298.
3. Miller V.A., Rigas J.R., Benedetti F.M., Verret A.L., Tong W.P., Kris M.G., Gill G.M., Loewen G.R., Truglia J.A., Ulm E.H., Warrell R.P. Jr. Initial trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res. 2:1996;471-475.
4. Heald P. The treatment of cutaneous T-cell lymphoma with a novel retinoid. Clin Lymphoma. 1:(Suppl 1):2000;S45-49.
5. Ellis C.N., Krach K.J. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 45:2001;S150-157.
6. Lebwohl M., Ali S. Treatment of psoriasis. Part 2 Systemic therapies. J Am Acad Dermatol. 45:2001;649-661.
7. Peck G.L., Olsen T.G., Yoder F.W., Strauss J.S., Downing D.T., Pandaya M., Butkus D., Arnaud-Battandier J. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med. 300:1979;329-333.
8. Ferrari A.C., Stone N., Stock R., Bednar M., Esseesse I., Singh H., Baldwin Y., Mandeli J. 13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients report of a phase II randomized study. J Clin Oncol. 20:2002;538-544.
9. Belden T.L., Ragucci D.P. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma. Pharmacotherapy. 22:2002;645-648.
10. Zech L.A., Gross E.G., Peck G.L., Brewer H.B. Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. A prospective study. Arch Dermatol. 119:1983;987-993.
11. Singh B.K., Mehta J.L. Management of dyslipidemia in the primary prevention of coronary heart disease. Curr Opin Cardiol. 17:2002;503-511.
12. Cameron J.L. Lipid abnormalities and acute pancreatitis. Hosp Pract. 12:(4):1977;95-101.
13. Yadav D., Pitchumoni C.S. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 36:2003;54-62.
14. Radcliffe J.D., Czajka-Narins D.M. Partial replacement of dietary casein with soy protein isolate can reduce the severity of retinoid-induced hypertriglyceridemia. Plant Foods Hum Nutr. 52:1998;97-108.
15. Radcliffe J.D., Imrhan V.L., Hsueh A.M. The use of soy protein isolate to reduce the severity of 13-cis retinoic acid-induced hypertriglyceridemia. Cancer Detect Prev. 22:1998;526-532.
16. Radcliffe J.D., Czajka-Narins D.M. Use of arginine to reduce the severity of retinoid-induced hypertriglyceridemia. Nutr Cancer. 36:2000;200-206.
17. Cohen P.R. The use of gemfibrozil in a patient with chronic myelogenous leukemia to successfully manage retinoid-induced hypertriglyceridemia. Clin Investig. 71:1993;74-77.
18. Farmer J.A., Gotto A.M. Jr. Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 9:1995;825-847.
19. Ashley J.M., Lowe N.J., Borok M.E., Alfin-Slater R.B. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy. J Am Acad Dermatol. 19:1988;76-82.
20. Lowe N.J., Borok M.E., Ashley J.M., Alfin-Slater R.B. Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy. Arch Dermatol. 124:1998;177-178.
21. Marsden J.R. Effect of dietary fish oil on hyperlipidemia due to isotretinoin and etretinate. Hum Toxicol. 6:1987;219-222.
22. Lindamood C. 3rd, MacThigpen L., Giles H.D., Makovec G.T., McCarthy D.J., Hill D.L. Modification of retinyl acetate toxicity in rats by co-administration of menhaden oil. Fundam Appl Toxicol. 12:1989;567-578.
23. Edwards M.S., Radcliffe J.D. Inhibition of retinyl acetate induced hyperlipidemia in the rat by dietary fish oil. Biochem Arch. 5:1989;309-313.
24. Podelkewicz C., Seufert J., Holman R. Requirements of the female rat for linoleic and linolenic acids. J Nutr. 94:1968;138-146.
25. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 27:1986;114-120.
26. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476-482.
27. Siedel J., Hagele E.O., Ziegenhorn J., Wahlefeld A.W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 29:1983;1075-1080.
28. Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 23:1977;882-884.
29. Gadde R.R., Burton F.W. Simple reversed-phase high-performance liquid chroma-tographic method for 13-cis-retinoic acid in serum. J Chromatogr. 593:1992;41-46.
30. Gerber L.E., Erdman J.W. Jr. Hyperlipidemia in rats fed retinoic acid. Lipids. 16:1981;496-501.
31. Gustafson S., Vahlquist C., Sjoblom L., Eklund A., Vahlquist A. Metabolism of very low density lipoproteins in rats with isotretinoin (13-cis retinoic acid)-induced hyperlipidemia. J Lipid Res. 31:1990;183-190.
32. Vahlquist C., Lithell H., Michaëlsson G., Selinus I., Vahlquist A., Vessby B. Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin. Acta Derm Venereol. 67:1987;139-144.
33. Ribeiro A., Mangeney M., Cardot P., Loriette C., Rayssigeur Y., Chambaz J., Bereziat G. Effect of dietary fish oil and corn oil on lipid metabolism and apolipoprotein gene expression by rat liver. Eur J Biochem. 196:1991;499-507.
34. Geelen M.J., Schoots W.J., Bijleveld C., Beynen A.C. Dietary medium-chain fatty acids raise and (n-3) polyunsaturated fatty acids lower hepatic triacylglycerol synthesis in rats. J Nutr. 125:1995;2449-2456.
35. Herzberg G.R., Rogerson M. The effect of dietary fish oil on muscle and adipose tissue lipoprotein lipase. Lipids. 24:1989;351-353.
36. Baltzell J.K., Wooten J.T., Otto D.A. Lipoprotein lipase in rats fed fish oil apparent relationship to plasma insulin levels. Lipids. 26:1991;289-294.
37. Demoz A., Willumsen N., Berge R.K. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids. 27:1992;968-971.
38. Shimura T., Miura T., Usami M., Ishihara E., Tanigawa K., Ishida H., Seino Y. Docosahexaenoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM). Biol Pharm Bull. 20:1997;507-510.
39. Iritani N., Suga A., Fukuda H., Katsurada A., Tanaka T. Effects of dietary casein and soybean protein on triglyceride turnover in rat liver. J Nutr Sci Vitaminol (Tokyo). 34:1988;309-315.
40. Pfeuffer M., Barth C.A. Modulation of very low-density lipoprotein secretion by dietary protein is age-dependent in rats. Ann Nutr Metab. 30:1986;281-288.
41. Iritani N., Hosomi H., Fukuda H., Tada K., Ikeda H. Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats. J Nutr. 126:1996;380-388.
42. Demonty I., Lamarche B., Deshaies Y., Jacques H. Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat. J Nutr Biochem. 13:2002;671-677.
43. Mackness M.I., Bhatnagar D., Durrington P.N., Prais H., Haynes B., Morgan J., Borthwick L. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Eur J Clin Nutr. 48:1994;859-865.
44. Anderson J.W., Johnstone B.M., Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 333:1995;276-282.
45. Tidwell D.K., McNaughton J.P., Pellum L.K., McLaurin B.P., Chen S.C. Comparison of the effects of adding fish high or low in n-3 fatty acids to a diet conforming to the Dietary Guidelines for Americans. J Am Diet Assoc. 93:1993;1124-1128.
46. Mori T.A., Vandongen R., Beilin L.J., Burke V., Morris J., Richie J. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr. 59:1994;1060-1068.
47. Rabbani P.I., Sheikh N.M., Chirtel S.J., Jackson R., Ruffini G. Effects of long-term consumption of high doses of fish oil concentrates on clinical parameters in male and female rats. J Nutr Sci Vitaminol (Tokyo). 45:1999;553-565.
48. Morita T., Oh-hashi A., Takei K., Ikai M., Kasaoka S., Kiriyama S. Cholesterol-lowering effects of soybean, potato, and rice proteins depend on their low methionine contents in rats fed a cholesterol-free purified diet. J Nutr. 127:1997;470-477.
49. Bolego C., Baetta R., Bellosta S., Corsini A., Paoletti R. Safety considerations for statins. Curr Opin Lipidol. 13:2002;637-644.
50. Nordoy A., Hansen J.B., Brox J., Svensson B. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis. 11:2001;7-16.
51. Grundy S.M., Abrams J.J. Comparison of actions of soy protein and casein on metabolism of plasma lipoproteins and cholesterol in humans. Am J Clin Nutr. 38:1983;245-252.
52. Henkin Y., Como J.A., Oberman A. Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice. JAMA. 267:1992;961-968.
53. Donahoo W.T., Kosmiski L.A., Eckel R.H. Drugs causing dyslipoproteinemia. Endocrinol Metab Clin North Am. 27:1998;677-697.